These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37674985)

  • 1. Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells.
    Singh AK; Wang R; Lombardo KA; Praharaj M; Bullen CK; Um P; Gupta M; Srikrishna G; Davis S; Komm O; Illei PB; Ordonez AA; Bahr M; Huang J; Gupta A; Psoter KJ; Creisher PS; Li M; Pekosz A; Klein SL; Jain SK; Bivalacqua TJ; Yegnasubramanian S; Bishai WR
    iScience; 2023 Oct; 26(10):107733. PubMed ID: 37674985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation.
    Singh AK; Wang R; Lombardo KA; Praharaj M; Bullen CK; Um P; Davis S; Komm O; Illei PB; Ordonez AA; Bahr M; Huang J; Gupta A; Psoter KJ; Jain SK; Bivalacqua TJ; Yegnasubramanian S; Bishai WR
    bioRxiv; 2022 Mar; ():. PubMed ID: 35313583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge.
    Hilligan KL; Namasivayam S; Clancy CS; O'Mard D; Oland SD; Robertson SJ; Baker PJ; Castro E; Garza NL; Lafont BAP; Johnson R; Ronchese F; Mayer-Barber KD; Best SM; Sher A
    J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34889942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG mediated protection of the lung against experimental SARS-CoV-2 infection.
    Hilligan KL; Namasivayam S; Sher A
    Front Immunol; 2023; 14():1232764. PubMed ID: 37744331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.
    Pitt JM; Stavropoulos E; Redford PS; Beebe AM; Bancroft GJ; Young DB; O'Garra A
    J Immunol; 2012 Oct; 189(8):4079-87. PubMed ID: 22972927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-target effects of bacillus Calmette-Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19.
    Messina NL; Germano S; McElroy R; Rudraraju R; Bonnici R; Pittet LF; Neeland MR; Nicholson S; Subbarao K; Curtis N;
    Clin Transl Immunology; 2022; 11(4):e1387. PubMed ID: 35573165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG vaccination provides protection against IAV but not SARS-CoV-2.
    Kaufmann E; Khan N; Tran KA; Ulndreaj A; Pernet E; Fontes G; Lupien A; Desmeules P; McIntosh F; Abow A; Moorlag SJCFM; Debisarun P; Mossman K; Banerjee A; Karo-Atar D; Sadeghi M; Mubareka S; Vinh DC; King IL; Robbins CS; Behr MA; Netea MG; Joubert P; Divangahi M
    Cell Rep; 2022 Mar; 38(10):110502. PubMed ID: 35235831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective intravenous BCG vaccination induces enhanced immune signaling in the airways.
    Peters JM; Irvine EB; Rosenberg JM; Wadsworth MH; Hughes TK; Sutton M; Nyquist SK; Bromley JD; Mondal R; Roederer M; Seder RA; Darrah PA; Alter G; Flynn JL; Shalek AK; Fortune SM; Bryson BD
    bioRxiv; 2023 Jul; ():. PubMed ID: 37502895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
    Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
    Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice.
    Zhang BZ; Shuai H; Gong HR; Hu JC; Yan B; Yuen TT; Hu YF; Yoon C; Wang XL; Hou Y; Lin X; Huang X; Li R; Au-Yeung YM; Li W; Hu B; Chai Y; Yue M; Cai JP; Ling GS; Hung IF; Yuen KY; Chan JF; Huang JD; Chu H
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35446790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2.
    Tarabini RF; Rigo MM; Faustino Fonseca A; Rubin F; Bellé R; Kavraki LE; Ferreto TC; Amaral Antunes D; de Souza APD
    Front Immunol; 2021; 12():812176. PubMed ID: 35095907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial.
    Claus J; Ten Doesschate T; Gumbs C; van Werkhoven CH; van der Vaart TW; Janssen AB; Smits G; van Binnendijk R; van der Klis F; van Baarle D; Paganelli FL; Leavis H; Verhagen LM; Joosten SA; Bonten MJM; Netea MG; van de Wijgert JHHM;
    mBio; 2023 Apr; 14(2):e0035623. PubMed ID: 36976004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis, BCG Vaccination, and COVID-19: Are They Connected?
    Borges KCM; da Costa AC; de Souza Barbosa LC; Ribeiro KM; Dos Anjos LRB; Kipnis A; Junqueira-Kipnis AP
    Mini Rev Med Chem; 2022; 22(12):1631-1647. PubMed ID: 34983348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis.
    Perdomo C; Zedler U; Kühl AA; Lozza L; Saikali P; Sander LE; Vogelzang A; Kaufmann SH; Kupz A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27879332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil.
    Santos AP; Werneck GL; Dalvi APR; Dos Santos CC; Tierno PFGMM; Condelo HS; Macedo B; de Medeiros Leung JA; de Souza Nogueira J; Malvão L; Galliez R; Aguiar R; Stefan R; Knackfuss SM; da Silva EC; Castineiras TMPP; de Andrade Medronho R; E Silva JRL; Alves RLR; de Moraes Sobrino Porto LC; Rodrigues LS; Kritski AL; de Queiroz Mello FC
    Int J Infect Dis; 2023 May; 130():8-16. PubMed ID: 36841502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age.
    Burl S; Adetifa UJ; Cox M; Touray E; Ota MO; Marchant A; Whittle H; McShane H; Rowland-Jones SL; Flanagan KL
    J Immunol; 2010 Aug; 185(4):2620-8. PubMed ID: 20644160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections.
    Föhse K; Taks EJM; Moorlag SJCFM; Bonten MJM; van Crevel R; Ten Oever J; van Werkhoven CH; Netea MG; van de Maat JS; Hoogerwerf JJ
    Front Immunol; 2023; 14():980711. PubMed ID: 36875134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.